Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2
NCT: NCT07300579 · NOT_YET_RECRUITING
Brief Summary
VISION-2 is an international, multi-site, prospective observational cohort study of 20,000 patients undergoing noncardiac surgery. Continuous biometric data will be blindly collected for the first 30 postoperative days, in hospital and at home, using Vitaliti™. Following study enrollment and baseline data collection, follow up visits will occur in-hospital, at 30-days, and 1-year post-operatively. VISION-2 has 3 primary objectives, among participants who underwent noncardiac surgery, the investigators will: 1) determine the pattern and frequency of physiological precursors (i.e., biophysical signals) to MINS, BIMS, sepsis, and infection without sepsis; 2) build prediction models from these biophysical signals and their extracted features through supervised machine learning, for the prediction and early detection of those complications; and 3) build a biobank for evaluation of novel biomarkers.
Frequently Asked Questions
What is Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2?
Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2 is a clinical trial registered under NCT07300579. Current status: NOT_YET_RECRUITING.
What is the status of NCT07300579?
The current status of NCT07300579 (Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2) is: NOT_YET_RECRUITING.
When did Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2 start?
Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2 started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.